Copyright Reports & Markets. All rights reserved.

Global Biologic Therapeutic Drug Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Biologic Therapeutic Drug Market Status and Forecast (2017-2028)
      • 1.3.2 Global Biologic Therapeutic Drug Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Biologic Therapeutic Drug Supply by Company

    • 2.1 Global Biologic Therapeutic Drug Sales Volume by Company
    • 2.2 Global Biologic Therapeutic Drug Sales Value by Company
    • 2.3 Global Biologic Therapeutic Drug Price by Company
    • 2.4 Biologic Therapeutic Drug Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Biologic Therapeutic Drug Market Status by Type

    • 3.1 Biologic Therapeutic Drug Type Introduction
      • 3.1.1 Monoclonal Antibodies
      • 3.1.2 Therapeutic Proteins
      • 3.1.3 Vaccines
    • 3.2 Global Biologic Therapeutic Drug Market by Type
      • 3.2.1 Global Biologic Therapeutic Drug Sales Volume by Type (2017-2022)
      • 3.2.2 Global Biologic Therapeutic Drug Sales Value by Type (2017-2022)
      • 3.2.3 Global Biologic Therapeutic Drug Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Biologic Therapeutic Drug Market Status by Application

    • 4.1 Biologic Therapeutic Drug Segment by Application
      • 4.1.1 Clinical Medicine
      • 4.1.2 Laboratory
      • 4.1.3 Others
    • 4.2 Global Biologic Therapeutic Drug Market by Application
      • 4.2.1 Global Biologic Therapeutic Drug Sales Volume by Application (2017-2022)
      • 4.2.2 Global Biologic Therapeutic Drug Sales Value by Application (2017-2022)
      • 4.2.3 Global Biologic Therapeutic Drug Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Biologic Therapeutic Drug Market Status by Region

    • 5.1 Global Biologic Therapeutic Drug Market by Region
      • 5.1.1 Global Biologic Therapeutic Drug Sales Volume by Region
      • 5.1.2 Global Biologic Therapeutic Drug Sales Value by Region
    • 5.2 North America Biologic Therapeutic Drug Market Status
    • 5.3 Europe Biologic Therapeutic Drug Market Status
    • 5.4 Asia Pacific Biologic Therapeutic Drug Market Status
    • 5.5 Central & South America Biologic Therapeutic Drug Market Status
    • 5.6 Middle East & Africa Biologic Therapeutic Drug Market Status

    6 North America Biologic Therapeutic Drug Market Status

    • 6.1 North America Biologic Therapeutic Drug Market by Country
      • 6.1.1 North America Biologic Therapeutic Drug Sales Volume by Country (2017-2022)
      • 6.1.2 North America Biologic Therapeutic Drug Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Biologic Therapeutic Drug Market Status

    • 7.1 Europe Biologic Therapeutic Drug Market by Country
      • 7.1.1 Europe Biologic Therapeutic Drug Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Biologic Therapeutic Drug Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Biologic Therapeutic Drug Market Status

    • 8.1 Asia Pacific Biologic Therapeutic Drug Market by Country
      • 8.1.1 Asia Pacific Biologic Therapeutic Drug Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Biologic Therapeutic Drug Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Biologic Therapeutic Drug Market Status

    • 9.1 Central & South America Biologic Therapeutic Drug Market by Country
      • 9.1.1 Central & South America Biologic Therapeutic Drug Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Biologic Therapeutic Drug Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Biologic Therapeutic Drug Market Status

    • 10.1 Middle East & Africa Biologic Therapeutic Drug Market by Country
      • 10.1.1 Middle East & Africa Biologic Therapeutic Drug Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Biologic Therapeutic Drug Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Biologic Therapeutic Drug Manufacturing Cost Analysis
    • 11.5 Biologic Therapeutic Drug Sales Channel and Distributors Analysis
      • 11.5.1 Biologic Therapeutic Drug Sales Channel
      • 11.5.2 Biologic Therapeutic Drug Distributors
    • 11.6 Biologic Therapeutic Drug Downstream Major Buyers

    12 Global Biologic Therapeutic Drug Market Forecast by Type and by Application

    • 12.1 Global Biologic Therapeutic Drug Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Biologic Therapeutic Drug Forecast by Type
      • 12.2.1 Global Biologic Therapeutic Drug Sales Volume Forecast by Type
      • 12.2.2 Global Biologic Therapeutic Drug Sales Value Forecast by Type
      • 12.2.3 Global Biologic Therapeutic Drug Price Forecast by Type
    • 12.3 Global Biologic Therapeutic Drug Forecast by Application
      • 12.3.1 Global Biologic Therapeutic Drug Sales Volume Forecast by Application
      • 12.3.2 Global Biologic Therapeutic Drug Sales Value Forecast by Application
      • 12.3.3 Global Biologic Therapeutic Drug Price Forecast by Application

    13 Global Biologic Therapeutic Drug Market Forecast by Region/Country

    • 13.1 Global Biologic Therapeutic Drug Market Forecast by Region (2023-2028)
      • 13.1.1 Global Biologic Therapeutic Drug Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Biologic Therapeutic Drug Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Smith Medical
      • 14.1.1 Company Information
      • 14.1.2 Biologic Therapeutic Drug Product Introduction
      • 14.1.3 Smith Medical Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Retractable Technologies, Inc.
      • 14.2.1 Company Information
      • 14.2.2 Biologic Therapeutic Drug Product Introduction
      • 14.2.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Pfizer Inc.
      • 14.3.1 Company Information
      • 14.3.2 Biologic Therapeutic Drug Product Introduction
      • 14.3.3 Pfizer Inc. Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Novartis Global
      • 14.4.1 Company Information
      • 14.4.2 Biologic Therapeutic Drug Product Introduction
      • 14.4.3 Novartis Global Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Merck and Co. Inc.
      • 14.5.1 Company Information
      • 14.5.2 Biologic Therapeutic Drug Product Introduction
      • 14.5.3 Merck and Co. Inc. Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 H. Lundbeck A/S
      • 14.6.1 Company Information
      • 14.6.2 Biologic Therapeutic Drug Product Introduction
      • 14.6.3 H. Lundbeck A/S Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 GlaxoSmithKline Plc.
      • 14.7.1 Company Information
      • 14.7.2 Biologic Therapeutic Drug Product Introduction
      • 14.7.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Concord Biotech
      • 14.8.1 Company Information
      • 14.8.2 Biologic Therapeutic Drug Product Introduction
      • 14.8.3 Concord Biotech Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Aurobindo Pharma Ltd.
      • 14.9.1 Company Information
      • 14.9.2 Biologic Therapeutic Drug Product Introduction
      • 14.9.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 AstraZeneca
      • 14.10.1 Company Information
      • 14.10.2 Biologic Therapeutic Drug Product Introduction
      • 14.10.3 AstraZeneca Biologic Therapeutic Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Biologic Therapeutic Drug market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Biologic Therapeutic Drug industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Biologic Therapeutic Drug market is estimated at $ 355800 million in 2021, and projected to grow at a CAGR of 8.3% to $ 621700 million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Biologic Therapeutic Drug Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Biologic Therapeutic Drug market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Biologic Therapeutic Drug Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Biologic Therapeutic Drug industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Monoclonal Antibodies
      Therapeutic Proteins

      Segmented by Application
      Clinical Medicine
      Laboratory
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Pfizer Inc.
      Novartis Global
      Merck and Co. Inc.
      H. Lundbeck A/S
      GlaxoSmithKline Plc.
      Concord Biotech
      Aurobindo Pharma Ltd.
      AstraZeneca
      Buy now